Company Overview
Snapshot
Founded in January 2017 by Asaf Kleinbort, Shai Levi, and Eviatar Khen, MedOrion operates with 11–50 employees. The company has raised $8.8M across 7 funding rounds from 6 investors.
Business overview
MedOrion provides an AI-based Health Behavior Management (HBM) platform designed for health plans and risk-bearing providers. Its SaaS solution intelligently processes complex health data, individual behaviors, and external factors to create personalized, persuasive communication strategies. The platform aims to improve member health outcomes and reduce healthcare costs by increasing engagement in preventative care, such as cancer screenings. MedOrion operates within the Health Tech & Life Sciences sector, focusing on digital healthcare, patient engagement, and leveraging artificial intelligence and machine learning.
Strategic signal
In November 2024, MedOrion expanded its behavioral science software with a new CAHPS solution. This development indicates the company's strategic focus on enhancing patient experience and satisfaction metrics, which are critical for health plans and providers. For investors, this signals MedOrion's commitment to addressing key performance indicators in the healthcare industry, potentially strengthening its market position and value proposition.
Company Intelligence Q&A
- What is MedOrion's core offering?
- MedOrion offers an AI-based Health Behavior Management (HBM) platform that helps health plans and risk-bearing providers influence member health through personalized, data-driven communication strategies.
- When was MedOrion founded and by whom?
- MedOrion was founded in January 2017 by Asaf Kleinbort, Shai Levi, and Eviatar Khen.
- What significant product enhancement did MedOrion announce in November 2024?
- In November 2024, MedOrion announced the release of a new CAHPS solution, expanding its behavioral science software.
- What was a key achievement for MedOrion in February 2022?
- In February 2022, MedOrion's Health Behavior Software won Pfizer's Vaccines Global Innovation Challenge.